The August 2025 issue of CancerWorld is now out, lighting up the intersection of scientific ingenuity and the urgent fight for equity in global cancer care. With a striking two-sided cover, this edition embodies the dual narrative driving progress today: breakthrough innovation and relentless advocacy for access.
On one side, Dr. Jennifer Buell tells the story of MiNK Therapeutics and its groundbreaking off-the-shelf iNKT cell therapy – a quiet revolution that’s remapping the immuno-oncology landscape and offering new hope to patients everywhere.
On the other, Jayasree K. Iyer, CEO of the Access to Medicine Foundation, issues a powerful challenge to the industry: while treatments evolve at lightning speed, 80% of the world still faces insurmountable barriers to care. Her perspective is both a rallying cry and a pragmatic roadmap for transforming innovation into equitable reality.
Inside, CancerWorld 106 unfolds with ten transformative stories:
- AI’s Prognostic Frontier: How FaceAge leverages artificial intelligence to predict cancer survival outcomes from simple photographs, urging clinicians to rethink conventional prognostic markers.
- A Life in Teaching, a Battle with Lymphoma: Prof. Michel Goldman’s journey from immunologist to patient offers lessons in resilience that transcend the bounds of medicine.
- Survivor’s Voice: Sandy Duarte pens an open letter to oncologists, reminding the medical community that sometimes healing comes through empathy – a hug can heal as much as any drug.
- Hidden Dangers: A clinical probe into the connection between BRCA mutations and breast-implant-associated lymphoma – critical knowledge for survivors and clinicians.
- AI-Authored Reflection: Albertina, an AI, explores the delicate “art” of personalized hope, demonstrating that while algorithms guide, it is human connection that gives purpose.
- Palliative Care Legacy: Honoring Dr. Anne Merriman, whose pioneering work in palliative care has transformed lives across Africa and set a standard for compassionate medicine.
- Cancer Neuroscience Spotlight: Revisiting Winkler and Monje’s research, which has placed neuron-tumor interaction at the heart of the next era in brain cancer therapeutics.
- Global Equity Call: Jayasree K. Iyer’s actionable vision to bridge the chasm between treatment advances and worldwide access.
This issue continues its tradition of combining cutting-edge science with human stories, policy analysis, and cultural insight, setting the agenda for where cancer care is heading next.